The global burden of neurological diseases increases every year, affecting the quality of lives of billions of people. Having seen first-hand the sequelae of severe trauma and the limited options for those who have lost the ability to see, to hear, to move, I am deeply motivated to complement my background in engineering with molecular techniques to open new avenues of treatment. To this end, I plan to develop the use of molecular biological techniques as a viable means of therapy, diagnosis, and research. I believe this PhD will help me launch my career as an academic clinician working on translational research where I am close to both the patients and the research that will help them. Ultimately, I aspire to lead work to develop methods towards the understanding and treatment of sensorineural deficits using molecular biology for interface design, signal recording, manipulation and analysis, with applications for molecular-level control and sensing, allowing for high throughput neurological research. I am extremely grateful to Gates Cambridge for allowing me the opportunity to pursue this aspiration.
University of Cambridge Preclinical Medical Studies 2019